SuperworthNU Skin Enterprises EPS NUS
Diluted earnings per share by quarter and over the last twelve months, from 2009.
- Last 12 months, to Jun 30, 2026
- −$4.47
- Latest quarter, Q2 FY26
- −$5.14
- −1295% on a year earlier
- Fiscal year 2025
- $3.20
NU Skin Enterprises' earnings per share was −$4.47 over the twelve months to Jun 30, 2026, down 322% on a year earlier.
In its latest quarter, Q2 FY26, it was −$5.14, down 1295% on the same quarter a year before.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $3.20 | n/a |
| FY2024 | −$2.95 | −1739% |
| FY2023 | $0.18 | −91% |
| FY2022 | $2.07 | −27% |
| FY2021 | $2.84 | −22% |
| FY2020 | $3.65 | +17% |
| FY2019 | $3.11 | +44% |
| FY2018 | $2.16 | −9% |
| FY2017 | $2.37 | −6% |
| FY2016 | $2.53 | +12% |
| FY2015 | $2.25 | −28% |
| FY2014 | $3.11 | −48% |
| FY2013 | $5.94 | +69% |
| FY2012 | $3.52 | +49% |
| FY2011 | $2.37 | +12% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$5.14 | −1295% | −$4.47 | |
| Q1 FY26 | $0.04 | −98% | $1.10 | |
| Q4 FY25 | $0.29 | n/a | $3.20 | |
| Q3 FY25 | $0.34 | +100% | $2.18 | |
| Q2 FY25 | $0.43 | n/a | $2.01 | |
| Q1 FY25 | $2.14 | n/a | −$0.80 | |
| Q4 FY24 | −$0.73 | −587% | −$2.95 | |
| Q3 FY24 | $0.17 | n/a | −$2.07 | |
| Q2 FY24 | −$2.38 | −541% | −$2.98 | |
| Q1 FY24 | −$0.01 | −104% | −$0.06 | |
| Q4 FY23 | $0.15 | −87% | $0.18 | |
| Q3 FY23 | −$0.74 | n/a | $1.18 |
Against its peers
Companies in Healthcare nearest NU Skin Enterprises' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| NUSNU Skin Enterprises | −$4.47 | −322% a year |
| UTMDUtah Medical Products | $3.28 | −12% a year |
| ELMDElectromed | $1.31 | +56% a year |
| NATRNatures Sunshine Products | $1.01 | +36% a year |
| PLXProtalix BioTherapeutics | $0.23 | +283% a year |
| PDEXPro DEX | $4.11 | +52% a year |
| INFUInfuSystem | $0.41 | +78% a year |
| VMDViemed Healthcare | $0.36 | +6% a year |
| EMBCEmbecta | $1.47 | +3% a year |
| ARVNArvinas | $0.16 | |
| NRCNRC Health | $0.25 | −67% a year |
| Peer median | $0.71 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on NU Skin Enterprises
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.